CELLTRION’S COVID-19 ANTIBODY TREATMENT CONFIRMED TO NEUTRALIZE VIRUS VARIANT

Highlights –

• Celltrion’s COVID-19 antibody treatment confirmed to neutralize virus variant.
• The company’s CT-P59, an anti-COVID-19 monoclonal antibody treatment neutralized the British virus variant.
• The company has also t...

S. KOREA APPROVES CELLTRION INC.’S COVID-19 ANTIBODY TREATMENT WITH CONDITIONS

Highlights –

• S. Korea approves Celltrion Inc.’s COVID-19 antibody treatment with conditions.
• The country’s drug safety agency has given conditional marketing authorization of CT-P59.
• Celltrion plans to conduct a global pha...

SOUTH KOREA’S OWN COVID-19 VACCINE TO BE DEVELOPED LATE NEXT YEAR

Highlights –

• South Korea’s own COVID-19 vaccine to be developed late next year.
• South Korean Prime Minister announced the same on Thursday.
• Whereas foreign vaccines are scheduled to be administered starting early next year.
...

S. KOREA GOVERNMENT TO INVEST $470 BILLION IN BIOTECHNOLOGY IN FISCAL 2021

Highlights –

• S. Korea government to invest $470 billion in biotechnology in fiscal 2021.
• The country’s Ministry of Science and ICT represents a 24.9% hike from 2020.
• Until 2030 the government plans to spend a total of 2.2 trilli...

SOUTH KOREAN PHARMAS JOIN NATION-FRAUGHT RACE TO DEVELOP COVID-19 VACCINE

• South Korean pharmaceutical companies have joined the rat race to develop vaccines and treatments for the novel coronavirus, and several of them have received the nod for clinical trials from the country's drug safety agency.
• Among the front-runners is Celltrion Inc.'s ...